Abstract: Sjö gren's syndrome is an autoimmune disease characterized by lymphocytic infiltration of the salivary glands. In the NOD mouse, a model for this disease, the development of lymphocytic infiltrates in the salivary glands is preceded by an accumulation of dendritic cells (DC). Given the key importance of DC in regulating the immune response, we characterized the DC isolated from NOD salivary glands. These DC lacked membrane expression of CCR5, whereas DC from control salivary glands did express this molecule. The lack of expression was present already prior to the onset of lymphocytic infiltration, indicating that this was not the result of ongoing inflammation. DC from other sources in the NOD mouse also showed a decrease in CCR5 expression. The lack of CCR5 expression in the NOD salivary gland was accompanied by an increase in inflammatory chemokines. Furthermore, DC from CCR5؊/؊ animals or DC treated with a CCR5 antagonist showed increased secretion of IL-12. Interestingly, in Sjö gren's syndrome patients, CCR5 expression on circulating monocytes was decreased and correlated to increased levels of IL-12. These data indicate that CCR5 has regulatory properties and that the lack of CCR5 in NOD DC contributes to the proinflammatory environment in the salivary glands.
INTRODUCTION
The NOD mouse is frequently used as a model to study the development of primary Sjögren's syndrome (pSjS) [1, 2] . Similar to human patients, these mice develop lymphocytic infiltrates in the salivary glands and finally show a decreased salivary flow. The lymphocytic infiltrates start to develop at approximately 7 weeks of age and show an increasing structural organization [2] . Earlier research in our laboratory has shown that the influx of lymphocytes is preceded by an accumulation of dendritic cells (DC) [2] . DC are potent APC capable of stimulating naïve and memory T cells and boosting B cell responses, thus playing a key role in the initiation of the immune response [3, 4] . Furthermore, DC are crucial to the development of tolerance, preventing harmful immune responses against harmless antigens [5, 6] . To fully exert their sentinel function, DC migrate from the blood into tissues and further to the draining lymph nodes. This migration is a complex, multi-step process, tightly regulated by numerous molecules including chemokines and their receptors [7, 8] .
The chemokine family contains a large number of proteins, characterized by their small size and conserved cysteine residues [9] . Most chemokines bind and signal through several receptors, and one receptor usually has multiple ligands [9, 10] , creating a highly complex network of interactions. Chemokine receptors are G-protein-coupled 7-transmembrane receptors, which have differential expression patterns on various leukocyte subsets [11] . On DC, the expression of chemokine receptors is linked to their state of maturation. For example, immature DC express CXCR4 and CCR1, -2, and -5, most of which are down-regulated after exposure to an activating stimulus [12, 13] . Besides cell trafficking, chemokine receptors have been described to regulate several other processes in DC, including endocytosis, dendrite formation, cell survival, and maturation of DC [14 -18] .
Given the importance of DC in the immune response, the expression of chemokine receptors in the DC accumulating in the NOD salivary glands was determined. Most strikingly, a complete lack of CCR5 expression was observed in these cells. Earlier, it has been shown that mice deficient in CCR5 display excessive immune responses, for example, in an influenza model [19] . Therefore, we hypothesized that the lack of CCR5 results in a proinflammatory environment. The results indeed show an immunoregulatory role for CCR5 in DC, both by scavenging of inflammatory ligands and by regulating the secretion of IL-12.
MATERIALS AND METHODS

Animals
Female C57BL/6 and CCR5Ϫ/Ϫ mice were obtained from Harlan (Horst, The Netherlands) and Jackson ImmunoResearch Laboratories (Bar Harbor, ME, USA), respectively. NOD/LTj mice were bred in our own facility under specified pathogen-free conditions. Animals were used at the age of 5-20 weeks. All mice were supplied with water and standard chow ad libitum. Experimental procedures were approved by the Erasmus University Animal Ethics Committee (Rotterdam, The Netherlands).
Human materials
Heparinized blood and serum samples were obtained from female pSjS patients (mean age 52.7Ϯ16.4; mean disease duration 6.6Ϯ7.8 years) at Erasmus MC (Rotterdam, The Netherlands). Inclusion criteria consisted of a positive diagnosis, according to the criteria of the American-European consensus group [20] , and the absence of other rheumatic or autoimmune disorders. Control blood samples were obtained from female volunteers (mean age 45.8Ϯ6.1) not suffering from autoimmune diseases or taking immunosuppressive medication. The Medical Ethical Committee of Erasmus MC approved this study, and all subjects gave informed consent.
PBMC were isolated from peripheral blood using a Ficoll gradient (Amersham, Little Chalfont, UK).
Isolation of CD11cϩ cells from tissue
Organs were removed and cleared of adipose tissue and lymph nodes. Tissue was digested by Liberase (Roche, Woerden, The Netherlands) treatment at 37°C and washed twice in PBS containing 10% FCS. Subsequently, cells were cleared from debris using a Ficoll (Amersham Biosciences, Uppsala, Sweden) gradient. Cells appearing at the interface were incubated with mouse CD11c microbeads (Miltenyi, Bergisch Gladbach, Germany), according to the manufacturer's protocol and isolated using the AutoMACS (Miltenyi) system.
Flow cytometry
Cells were resuspended in PBS containing 1% BSA and incubated with primary antibodies, which were biotinylated MHC class II (C57BL/6 clone ER-TR3; NOD clone 10.2.16), biotinylated CD11c, CD8␣-FITC, CD80-PE, CD86-FITC, CD40-PE, CXCR4-PE, and CCR5-PE (all BD Biosciences, San Jose, CA, USA). For human material, CCR5-PE-Cy5 (BD Biosciences) was used. Afterwards, cells were washed twice and when appropriate, incubated with streptavidin-allophycocyanin (BD Biosciences). For intracellular CCR5 staining, surface CCR5 was blocked by incubation with a tenfold excess of unlabeled anti-CCR5 antibody (BD Biosciences). Next, cells were fixed using 2% paraformaldehyde and permeabilized using 0.5% saponin. Cells were then incubated with labeled CCR5 antibody diluted in 0.5% saponin, washed, and resuspended in 1% BSA. Cell suspensions were analyzed using a FACSCalibur (Becton Dickenson, San Diego, CA, USA) and WinMDI software (Microsoft Co., Redmont, WA, USA). Expression was calculated as mean fluorescence intensity (MFI) specific staining -MFI isotype control. For calculation of relative expression levels, expression of C57Bl/6 was set to 1, and NOD levels were calculated accordingly.
Cytokine determination
Levels of IL-12p40 in supernatant were determined using an IL-12p40 Duoset kit (R&D Systems Inc., Minneapolis, MN, USA), and serum levels of IL-12 were determined using a human cytokine 25-plex AB bead kit (Biosource, Camarillo, CA, USA), according to the manufacturer's suggestions. Induction of IL-12 was calculated as secretion after LPS stimulation divided by secretion without stimulus.
Bone marrow-derived DC (BMDC) culture BM was isolated from femur and cultured in RPMI-1640 medium (BioWhittaker, Verviers, Belgium), supplemented with 10% FCS (BioWhittaker), 50 M ␤-ME (Sigma Aldrich, Deisenhofen, Germany), and 20 ng/mL recombinant mouse GM-CSF (Biosource) for 9 days. To enrich immature DC, cells were incubated with anti-CD86 antibody (clone GL-1), washed, labeled with goat anti-rat microbeads (Miltenyi), and separated using the AutoMACS (Miltenyi) system. For stimulation experiments, BMDC were incubated with Met-RANTES (10 g/mL, R&D Systems Inc.), where appropriate, and stimulated using LPS (5 ng/mL, Sigma Aldrich) for 16 h, after which supernatants were collected.
RNA isolation and RT-PCR
RNA was isolated from submandibular glands (SMG) using the RNeasy Mini kit (Qiagen, Valencia, CA, USA), according to the manufacturer's suggestions. cDNA was generated using Superscript II (Invitrogen, Carlsbad, CA, USA) and random hexamer primers (Amersham). RT-PCR analysis was carried out using predesigned primer/probe sets (Applied Biosystems, Foster City, CA, USA), according to the manufacturer's suggestions. For calculation of relative expression, all samples were normalized against expression of the household gene Abl.
Statistics
Data were analyzed using Student's t-test, except for relative data (C57BL/6 set to 1), where the Mann Whitney U-test was used. Error bars represent SD. Correlations were calculated using Spearman's Rank test. All statistical analyses were performed using SPSS software (SPSS Inc., Chicago, IL, USA) and were considered significant if P Ͻ 0.05.
RESULTS
Lack of CCR5 expression on CD11cϩ cells in NOD salivary gland
CD11cϩ cells were isolated from SMG of NOD and control mice, and the chemokine receptor expression pattern was analyzed by flow cytometry. CD11cϩ cells isolated from control mice showed expression of CXCR4 and CCR5 (Fig. 1A) , NOD CD11cϩ showed a somewhat decreased expression whereas of CXCR4 and completely lacked expression of CCR5 (Fig. 1A) . As CCR5 is down-regulated during the activation of DC, the lack of CCR5 could be a result of an increased activation of CD11cϩ cells in NOD SMG. However, expression of the activation markers CD40, CD80, and CD86 did not show a significant pattern of up-regulation (Fig. 1, A and B) .
As expression of CCR5 can be influenced by inflammatory environmental stimuli, expression levels may be influenced by the ongoing inflammatory process in the salivary glands of NOD mice. Therefore, CD11cϩ cells isolated from SMG prior to the development of lymphocytic infiltrates (5 weeks) were compared with CD11cϩ from SMG with full-blown inflammatory infiltrations (15 weeks). At both ages, CD11cϩ from control mice showed clear expression of CCR5 (Fig. 1C) , whereas expression in NOD was already below detection level at 5 weeks of age. The absence of activation marker upregulation in combination with the fact that CCR5 expression is undetectable already prior to the onset of lymphocytic infiltration indicates that the lack of expression is not caused by the ongoing inflammation in the SMG.
Decreased CCR5 expression in NOD DC derived from other sources
To determine if the lack of CCR5 expression is tissue-specific or a general phenomenon in NOD mice, CD11cϩ cells from other in vitro and in vivo sources were studied. CD11cϩ/ autofluorescence low DC derived from the lungs of NOD mice showed a clearly decreased expression of CCR5 when compared with control mice ( Fig. 2A) . Similarly, DC cultured from BM (BMDC) in the presence of GM-CSF showed a significantly decreased expression of CCR5 (Fig. 2B) .
Lack of surface CCR5 is accompanied by increased intracellular CCR5 in NOD SMG
CCR5 is a cycling receptor, undergoing rounds of ligandbinding, internalization, uncoupling of the receptor, and relocalization to the cell surface [21] . Therefore, the lack of CCR5 on CD11cϩ cells in NOD SMG could be a result of an altered localization of this molecule. Indeed, when intracellular expression of CCR5 was studied, an increased expression was found in CD11cϩ cells isolated from NOD SMG when compared with CD11cϩ from control mice (Fig. 2C) . However, in BMDC, no increase in intracellular CCR5 was found (Fig. 2D) , indicating that the altered CCR5 localization in SMG may be dependent on the microenvironment. 
Lack of CCR5 receptor expression may lead to increased free ligand
The lack of CCR5 expression on the surface of CD11cϩ cells in the SMG of NOD mice may influence biologically available levels of CCR5 ligands CCL3, CCL4, and CCL5. When measured in total salivary gland, mRNA levels of these chemokines tended to be somewhat higher in NOD than in control mice (Fig. 3A) . Furthermore, in control mice, these chemokines can be scavenged from the environment by surface CCR5 on tissue CD11cϩ cells, thus decreasing the level of free, active ligand. This results in a balanced ratio between CCR5 ligands and CCR5 itself. As a result of the lack of surface CCR5 expression, this mechanism is not available in NOD mice, which would be indicated by an increased CCR5 ligand:CCR5 ratio. Indeed, ratios of CCL3, CCL4, and CCL5 relative to the level of CCR5 were increased significantly in the NOD salivary gland (Fig. 3B) .
Lack of CCR5 signaling leads to increased IL-12 secretion
CCR5 has been linked to the regulation of IL-12 secretion in an oral-tolerance model [22] . To test whether CCR5 also regulates IL-12 specifically in DC, BMDC were cultured from C57BL/6 and CCR5Ϫ/Ϫ mice and stimulated with LPS. Secretion of IL-12, as well as relative induction, indeed was higher in CCR5Ϫ/Ϫ mice (Fig. 4A) . To exclude a role for the knockout procedure, wild-type BMDC treated with the CCR5 antagonist Met-RANTES [23] were compared with untreated cells. Again, secretion and induction of IL-12 were higher in BMDC treated with Met-RANTES (Fig. 4B) . This supports the idea that CCR5 is involved in the regulation of IL-12 secretion.
Decreased levels of CCR5 in pSjS patients
The relevance of decreased CCR5 expression in human pSjS was explored by measuring CCR5 expression on monocytes, which are generally considered the most important blood precursors for DC. Similar to the mouse model, a significant decrease in surface expression of CCR5 was found in monocytes of pSjS patients when compared with monocytes of controls (Fig. 5A) . Interestingly, the level of CCR5 expression was negatively correlated to the serum concentration of IL-12 ( 
DISCUSSION
No expression of CCR5 was found on CD11cϩ cells in the salivary glands of NOD mice, whereas control mice did show expression. As the lack of CCR5 was present prior to the development of lymphocytic infiltrates, and expression of activation markers was not increased, this was not the result of an increased state of DC activation as a result of the ongoing inflammation. In CD11cϩ cells isolated from NOD mice, an increase in intracellular CCR5 was detected, indicating that the lack of surface expression may at least partly be explained by an altered subcellular localization of the molecule. However, BMDC and lung DC also showed decreased CCR5 expression, which was not accompanied by increased intracellular levels, suggesting a different cause such as a genetic deficiency. Therefore, the complete lack of CCR5 on SMG CD11cϩ cells might be partially explained by an altered subcellular localization and partially by another, possibly genetic factor. The lack of surface CCR5 expression appears to have functional consequences, as NOD mice show defective recruitment in response to a CCR5 ligand in an in vivo migration model [24] .
CCR5 was initially thought to be involved in directing immature DC to tissue sites [13] . Surprisingly, in the steadystate, CCR5Ϫ/Ϫ mice develop normally and show cell numbers and lymphoid architecture similar to wild-type animals [25] . Furthermore, several reports show normal macrophage recruitment in CCR5Ϫ/Ϫ mice during inflammation [19, [25] [26] [27] . These findings may be explained in light of the high redundancy in the chemokine system. In CCR5-deficient cells, migration is probably regulated by other chemokine molecules, such as CCR1 and CCR2. RNA levels of these receptors were comparable in NOD and control SMG (data not shown), which may explain the presence of DC in NOD SMG, despite the lack of CCR5.
In accordance with previous studies in CCR5Ϫ/Ϫ mice [19, 26, 28] , mRNA of CCR5 ligands tended to be increased in NOD SMG. In addition, the lack of expression of CCR5 in DC isolated from NOD SMG leads to a lack of scavenging by this receptor, thus contributing to increased amounts of free, biologically available ligands. Such scavenging by CCR5 has been reported to play a role in the control as well as the resolution of immune responses [29, 30] . The increased availability of free CCL3, -4, and -5 may lead to an enhanced influx of other leukocytes, such as T cell and macrophages, as is seen in the salivary glands of NOD mice. One could argue that the increased levels of CCR5 ligand are causative rather than the result of decreased expression of CCR5 as a result of receptor internalization. However, as DC cultured from BM of NOD mice in vitro also show strong defects in expression of CCR5, Fig. 3 . Ratio of CCR5 ligands:CCR5 is increased in NOD SMG. Total mRNA was isolated from SMG, and expression levels of CCL3, CCL4, CCL5, and CCR5 were determined by RT-PCR (nϭ5). Error bars represent SD; *, P Ͻ 0.05. this appears to be unlikely. Furthermore, extended exposure of wild-type DC to CCR5 ligands does not lead to decreased expression of the receptor, with the exception of CCL3 at very high concentrations (data not shown). However, even is this case, expression of CCR5 remained at clearly detectable levels, unlike NOD DC in vivo.
In a mouse model for experimental autoimmune encephalitis, oral tolerance could be induced in wild-type, but not in CCR5Ϫ/Ϫ mice [22] . Furthermore, in the CCR5Ϫ/Ϫ mice, increased levels of IL-12 were observed in the GALT. The current study shows that DC derived from CCR5Ϫ/Ϫ or DC treated with a CCR5 antagonist show increased secretion of IL-12p40 compared with wild-type BMDC. Although levels were low, results showed a similar trend for IL-12p70 (data not shown). Earlier, increased secretion of IL-12 in response to various stimuli was reported in NOD DC and NOD macrophages, which also show decreased expression of CCR5, and this was indeed the result of autocrine signaling [31, 32] . Interestingly, in pSjS patients, decreased levels of CCR5 were observed in peripheral monocytes, and this correlated negatively with the level of IL-12 in the serum, supporting the hypothesis that CCR5 plays a role in the regulation of IL-12 in DC.
IL-12 secreted by DC is a well-known inducer of Th1 cells and plays an important role in the development of various immune responses [33] . In the NOD mouse model, addition of IL-12 leads to acceleration of the development of diabetes, whereas inhibition of IL-12 using an antagonist has a protective effect [34, 35] . Unfortunately, the salivary glands were not studied in these experiments, but increased expression of IL-12 is found in the salivary glands of pSjS patients [36] . Furthermore, transgenic mice overexpressing IL-12 develop infiltrations in their salivary glands similar to those seen in NOD mice, indicating an important role for this cytokine in the pathogenesis of pSjS [37] .
In a recent report, CCR5Ϫ/Ϫ mice showed an increased antibody production in the setting of a cardiac transplant [38] . These antibodies were highly functional, as CCR5Ϫ/Ϫ mice showed acute humoral rejection, which could be transferred by serum [39] . Similar increases in levels of antibody were observed earlier in an infection model in CCR5Ϫ/Ϫ animals [25] . In both studies, numbers of IL-4-producing T cells were increased, suggesting a skewing of the immune system toward antibody production in the absence of CCR5. Increased levels of autoantibodies are a well-known phenomenon in human pSjS patients as well as NOD mice [40 -42] . The lack of CCR5 on DC may play a role in this by increasing the numbers of IL-4-producing T cells, thus stimulating the generation of autoantibodies. Indeed, in NOD mice, IL-4 is of crucial importance to the development of pSjS-like symptoms, as NOD.IL-4Ϫ/Ϫ mice do not develop salivary dysfunction [43] . Interestingly, in the patient cohort described in this study, CCR5 expression was lower in patients who were positive for the well-known autoantibody SS-B, although this did not reach statistical significance (Pϭ0.067; data not shown).
The hypothesis that the lack of CCR5 plays a role in the increased expression of IL-12 as well as IL-4 appears somewhat at odds with the original Th1/Th2 paradigm. However, it has now been clearly shown that the two responses are not as mutually exclusive as previously thought, and in pSjS patients, increased numbers of IFN-␥-and IL-4-producing T cells are found [44 -46] . Furthermore, the NOD mouse, which is re- Fig. 4 . IL-12 secretion in the absence of CCR5 signaling. (A) BMDC were generated in the presence of GM-CSF from wild-type (WT) and CCR5Ϫ/Ϫ animals. Cells were then stimulated using LPS (5 ng/mL), and IL-12p40 was measured in the supernatant by ELISA (nϭ6). Error bars represent SD. (B) BMDC were generated in the presence of GM-CSF from wild-type animals, treated with met-RANTES (met), and stimulated using LPS (5 ng/mL). IL-12p40 levels in the supernatants were measured by ELISA (nϭ3). Bars represent mean values; error bars represent SD. garded as a strongly Th1-biased animal, displays a more aggressive form of the stereotypical Th2 condition asthma [47] .
In humans, the role of CCR5 polymorphisms [48, 49] has been studied in various autoimmune diseases. In diabetes and systemic lupus erythematosus, no association was found between the frequency of CCR5 polymorphisms and disease incidence [50 -52] , but more complications and interestingly, higher levels of autoantibodies were found in patients with polymorphic CCR5 alleles [52] [53] [54] . Only one earlier study focused on CCR5 in pSjS and concluded that a CCR5 mutation may somewhat protect against pSjS, contradicting our results [55] . However, in that study, only one polymorphism was included, leaving the possibility that other polymorphisms influenced the results. In the current study, CCR5 was determined at the protein level, thus resulting in actual expression levels rather than genetics.
The function of CCR5 in the migration of various cell types has been studied extensively. This study shows that in addition, CCR5 is a regulatory molecule and that its expression on immature DC is likely to contribute to the tolerogenic phenotype of this subset. In the salivary gland of the NOD mouse model for pSjS, the lack of CCR5 on DC contributes to a more proinflammatory environment.
